Arginine metabolism in asthma

Immunology and Allergy Clinics of North America

Volumn 34, Issue 4, 2014, Pages 767-775

  Scott, Jeremy A ^a   Grasemann, Hartmut ^b  

^a LAKEHEAD UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

ADMA; Agmatine; Arginase; Arginine metabolism; Citrulline; Nitric oxide synthase; Ornithine; Polyamine

Indexed keywords

ARGINASE; ARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; PROTEIN ARGININE METHYLTRANSFERASE; ANTIASTHMATIC AGENT; N,N-DIMETHYLARGININE;

AIRWAY CONSTRICTION; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ASTHMA; BIODEGRADATION; CLINICAL STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; EXHALED BREATH CONDENSATE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OBESITY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT PARAMETERS; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BRONCHIAL HYPERREACTIVITY; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY;

ANIMALS; ANTI-ASTHMATIC AGENTS; ARGININE; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; MOLECULAR TARGETED THERAPY; NITRIC OXIDE SYNTHASE;

EID: 84922291732     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.07.007     Document Type: Review

References (47)

1. De Sanctis G.T., MacLean J.A., Hamada K., et al. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. JExp Med 1999, 189:1621-1630.
2. North M.L., Khanna N., Marsden P.A., et al. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009, 296:L911-L920.
3. Meurs H., McKay S., Maarsingh H., et al. Increased arginase activity underlies allergen-induced deficiency of cnos-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002, 136:391-398.
4. Zimmermann N., King N.E., Laporte J., et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. JClin Invest 2003, 111:1863-1874.
5. Scott J.A., North M.L., Rafii M., et al. Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med 2011, 184:779-785.
6. Holguin F., Comhair S.A., Hazen S.L., et al. An association between l-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med 2013, 187:153-159.
7. Zakrzewicz D., Eickelberg O. From arginine methylation to adma: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med 2009, 9:5.
8. Yildirim A.O., Bulau P., Zakrzewicz D., et al. Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 2006, 35:436-443.
9. Bulau P., Zakrzewicz D., Kitowska K., et al. Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of adma. Am J Physiol Lung Cell Mol Physiol 2007, 292:L18-L24.
10. Ahmad T., Mabalirajan U., Ghosh B., et al. Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. Am J Respir Cell Mol Biol 2010, 42:3-8.
11. Ahmad T., Mabalirajan U., Sharma A., et al. Simvastatin improves epithelial dysfunction and airway hyperresponsiveness: from asymmetric dimethyl-arginine to asthma. Am J Respir Cell Mol Biol 2011, 44:531-539.
12. Sun Q.Z., Jiao F.F., Yang X.D., et al. Expression of protein arginine n-methyltransferases in e3 rat models of acute asthma. Nan Fang Yi Ke Da Xue Xue Bao 2010, 30:716-719. [in Chinese].
13. Sun Q., Yang X., Zhong B., et al. Upregulated protein arginine methyltransferase 1 by il-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats. JImmunol 2012, 188:3506-3512.
14. Closs E.I., Basha F.Z., Habermeier A., et al. Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hcat-2B. Nitric Oxide 1997, 1:65-73.
15. Strobel J., Mieth M., Endress B., et al. Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (cat1). JMol Cell Cardiol 2012, 53:392-400.
16. Bode-Boger S.M., Scalera F., Ignarro L.J. The L-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007, 114:295-306.
17. Pope A.J., Karrupiah K., Kearns P.N., et al. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. JBiol Chem 2009, 284:35338-35347.
18. Pope A.J., Karuppiah K., Cardounel A.J. Role of the prmt-ddah-adma axis in theregulation of endothelial nitric oxide production. Pharmacol Res 2009, 60:461-465.
19. Klein E., Weigel J., Buford M.C., et al. Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2010, 299:L816-L825.
20. Kinker K.G., Gibson A.M., Bass S.A., et al. Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma. PLoS One 2014, 9:e85148.
21. Aggarwal S., Gross C.M., Kumar S., et al. Dimethylarginine dimethylaminohydrolase ii overexpression attenuates LPS-mediated lung leak in acute lung injury. Am J Respir Cell Mol Biol 2014, 50:614-625.
22. Wells S.M., Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 2007, 36:520-528.
23. Wells S.M., Buford M.C., Migliaccio C.T., et al. Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. Am J Respir Cell Mol Biol 2009, 40:179-188.
24. North M.L., Grasemann H., Khanna N., et al. Increased ornithine-derived polyamines cause airway hyperresponsiveness in a mouse model of asthma. Am J Respir Cell Mol Biol 2013, 48:694-702.
25. Carraro S., Giordano G., Piacentini G., et al. Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. Chest 2013, 144:405-410.
26. Scott J.A., Gauvreau G.M., Grasemann H. Asymmetric dimethylarginine and asthma. Eur Respir J 2014, 43:647-648.
27. Riccioni G., Bucciarelli V., Verini M., et al. Adma, sdma, l-arginine and nitric oxide in allergic pediatric bronchial asthma. JBiol Regul Homeost Agents 2012, 26:561-566.
28. Lau E.M., Morgan P.E., Belousova E.G., et al. Asymmetric dimethylarginine and asthma: results from the childhood asthma prevention study. Eur Respir J 2013, 41:1234-1237.
29. Gonzalez J.R., Caceres A., Esko T., et al. Acommon 16p11.2 inversion underlies the joint susceptibility to asthma and obesity. Am J Hum Genet 2014, 94:361-372.
30. Kim H.Y., Lee H.J., Chang Y.J., et al. Interleukin-17-producing innate lymphoid cells and the nlrp3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 2014, 20:54-61.
31. Moore W.C., Meyers D.A., Wenzel S.E., National Heart Lung, Blood Institute's Severe Asthma Research Program, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010, 181:315-323.
32. Haldar P., Pavord I.D., Shaw D.E., et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008, 178:218-224.
33. Sutherland E.R., Goleva E., King T.S., Asthma Clinical Research Network, et al. Cluster analysis of obesity and asthma phenotypes. PLoS One 2012, 7:e36631.
34. Komakula S., Khatri S., Mermis J., et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 2007, 8:32.
35. Holguin F., Bleecker E.R., Busse W.W., et al. Obesity and asthma: an association modified by age of asthma onset. JAllergy Clin Immunol 2011, 127:1486-1493.e2.
36. Holguin F. Arginine and nitric oxide pathways in obesity-associated asthma. JAllergy (Cairo) 2013, 2013:714595.
37. Sterk P.J., Ricciardolo F.L. Clinical-biological phenotyping beyond inflammation in asthma delivers. Am J Respir Crit Care Med 2013, 187:117-118.
38. Mabalirajan U., Ahmad T., Leishangthem G.D., et al. Beneficial effects of high dose of l-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. JAllergy Clin Immunol 2010, 125:626-635.
39. Grasemann H., Tullis E., Ratjen F. Arandomized controlled trial of inhaled l-arginine in patients with cystic fibrosis. JCyst Fibros 2013, 12:468-474.
40. Kenyon N.J., Last M., Bratt J.M., et al. L-arginine supplementation and metabolism in asthma. Pharmaceuticals 2011, 4:187-201.
41. Balderas-Munoz K., Castillo-Martinez L., Orea-Tejeda A., et al. Improvement of ventricular function in systolic heart failure patients with oral l-citrulline supplementation. Cardiol J 2012, 19:612-617.
42. Wijnands K.A., Vink H., Briede J.J., et al. Citrulline a more suitable substrate than arginine to restore no production and the microcirculation during endotoxemia. PLoS One 2012, 7:e37439.
43. Morris C.R., Poljakovic M., Lavrisha L., et al. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004, 170:148-153.
44. Sousse L.E., Yamamoto Y., Enkhbaatar P., et al. Acute lung injury-induced collagen deposition is associated with elevated asymmetric dimethylarginine and arginase activity. Shock 2011, 35:282-288.
45. Tanaka H., Masuda T., Tokuoka S., et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 2001, 50:616-624.
46. Prado C.M., Martins M.A., Tiberio I.F. Nitric oxide in asthma physiopathology. ISRN Allergy 2011, 2011:832560.
47. Zeki A.A., Bratt J.M., Rabowsky M., et al. Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?. Transl Res 2010, 156:335-349.